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Background
The microbiota is essential to the functioning of the
immune system. The nasal milieu secretes immune
molecules that can be influenced by diverse bacteria. Hence
commensals that enhance anti-viral responses may confer
resistance to respiratory viral infection.
Our collaborators have identified 7 microbial state types
(CST) defined by indicator species in the nose and recently,
through analyses of nasal immune molecules, we have
categorized the nasal immune profile types into 8 groups
(IPT). Although the IPTs correlated with certain CSTs, the
influence of the nasal microbiome on susceptibility to
respiratory pathogens is still unknown.
Defining this complex relationship requires a relevant in
vitro model which recapitulates key aspects of the in vivo
nasal epithelium (pseudostratification, mucociliary
differentiation), can sustain stable bacterial communities in
a relevant environment (air-interfaced), and can support
infection with respiratory pathogens (e.g., Staphylococcus
aureus, influenza, SARS-CoV-2). Conventionally cultured
cells lack innate protective features such as mucus and cilia
and do not express physiological levels of innate immune
mediators or pathogen entry receptors. These epithelial
characteristics are crucial to reconstruct the complexity of
microbiome-host-pathogen interactions in a controlled in
vitro model. We have previously developed a nasal model
capable of being infected by SARS-CoV-2, however due to
variability in the source of cells, maintenance of culture
consistency was difficult to achieve. Some obstacles
included nonviable cells at isolation, fibroblast
contaminations, and early death of differentiated cells.
Hypothesis: In this study, we aim to optimize our current
nasal model to provide consistent cell cultures to support
bacterial co-cultures and SARS-CoV-2 infection studies.

Methods
Primary nasal epithelial cells were isolated from nasal
mucosa removed during sinus and base skull surgery for
non-inflammatory indications.
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Connective tissues were excised, followed by trypsin
(0.25% Trypsin/EDTA) incubation to isolate nasal
epithelial cells. Cells were plated into bovine type I
collagen coated flasks and grown in keratinocyte serum
free media (KSFM) supplemented with calcium chloride
(CaCl2). Epithelial differentiation into pseudostratified
columnar cells was induced by removing the apical media
and culturing at the air-liquid interface (ALI) in KSFM
supplemented with CaCl2. Calcium supplementation
conditions were separated into no calcium, 0.1 mM (low),
and 1.0 mM (high) during the cell growth phase followed
by cell seeding into transwells for the ALI differentiation
phase consisting of no calcium, 0.1 mM, and 1.0 mM
supplementations creating 9 conditions (see figure 1).
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Growth: Previous growth of isolated cells resulted in fibroblast contamination as the rate of
growth of fibroblastsAoutpaced epithelial cells. With supplementation
of 0.1 mM or 1.0 mM of CaCl2
B
in KSFM, it enhanced the growth of epithelial cells compared to no calcium added and indirectly
reduced fibroblast contamination (see figure 2). Ensuring greater growth of epithelial cells to
minimize fibroblasts was more effective than performing differential trypsin to remove fibroblast.
Differential trypsin removed epithelial cells in the process, which reduced the competition against
fibroblast growth.

We further optimized the isolation of cells from donor
tissue through trypsin-only incubation and enhanced the
growth of cells with supplementation of high CaCl2 (1.0
mM)
which
indirectly
minimized
fibroblast
contamination. Additionally, continuation of high CaCl2
supplementation during ALI prolonged the epithelial
layer and barrier integrity as measured by TEER.

ALI: In previous ALI cultures, cells began to undergo cell death at around 20 days post-ALI
condition, creating gaps in the confluent layer. Non-confluent epithelial models are ineffective barriers
against respiratory infections nor bacterial co-cultures. We found that ALI supplemented with high
CaCl2 achieved greater transepithelial electrical resistant (TEER) values up to day 28 post-ALI
compared to low calcium or no calcium supplementations in the ALI differentiation phase (see table
1).
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Significance
This study provides a foundation for future viralmicrobiota-host interaction models aimed at better
understanding the effects of the nasal microbiome on
susceptibility to respiratory pathogens using a consistent
and replicable model.
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Future Works
B
Figure 2. Day 3 post isolation of nasal epithelial cells grown in 3 different calcium concentrations. A)
Keratinocyte serum-free media (KSFM) with no calcium. B) KSFM supplemented with 0.1 mM of CaCl2. C)
KSFM supplemented with 1.0 mM of CaCl2. Photos taken under 50x total magnification
Figure 1. Conditions for supplementing calcium chloride into the
growth phase and differentiating air-liquid interface (ALI) phase.
Isolated tissues were cultured in no calcium, 0.1 mM, or 1.0 mM
calcium in the growth phase. Then, cells from each flask were
seeded into transwells and differentiated in no calcium (pink) , 0.1
mM (blue), or 1.0 mM calcium (orange) in the ALI differentiation
state.

Results
Optimal isolation is defined by viable nasal epithelial cells and
minimal fibroblast contamination
Isolation: Previous methods incubated tissues in Dispase
overnight prior to trypsin incubation to collect isolated cells
through cell strainers. However, we were successful in
isolating the cells with trypsin only with 80% cell viability via
Tryphan blue exclusion.

•

Continue to verify mucociliary differentiation using
hematoxylin and eosin (H&E) staining techniques

•

Create a baseline for SARS-CoV-2 luciferase intensity
at differ multiplicity of infection for our nasal model

•

Mimic IPT in vitro by treating nasal models with
cytokines to investigate susceptibilities of IPT to wildtype SARS-CoV-2 challenge
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